JP MORGAN/PUT/MCKESSON/460/0.01/15.11.24 Stock JP MORGAN/PUT/MCKESSON/460/0.01/15.11.24
Add to a list
To use this feature you must be a member
Log inSign up

JP MORGAN/PUT/MCKESSON/460/0.01/15.11.24 Stock

Warrant

DE000JK45JT1

Market Closed - Börse Stuttgart 02:40:51 2024-07-05 EDT
0.046 EUR +2.22% Intraday chart for JP MORGAN/PUT/MCKESSON/460/0.01/15.11.24
Current month+17.95%
1 month+15.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart MCKESSON CORPORATION
Chart JP MORGAN/PUT/MCKESSON/460/0.01/15.11.24

Latest news about MCKESSON CORPORATION

U.S. Supreme Court Asked To Define "Willfully" For Anti-Kickback Violation AQ
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading MT
McKesson ideaShare Ignites and Inspires Independent Community Pharmacies AQ
Rite Aid seeks bankruptcy court approval to cut $2 billion debt RE
More news

Quotes 5-day view

Date Price Change
24-07-05 0.046 +2.22%
24-07-04 0.045 +7.14%
24-07-03 0.042 0.00%
24-07-02 0.042 -2.33%
24-07-01 0.043 +10.26%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 02:40 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MCKESSON CORPORATION
Issuer J.P. Morgan
WKN JK45JT
ISINDE000JK45JT1
Date issued 2024-03-19
Strike 460 $
Maturity 2024-11-15 (132 Days)
Parity 100 : 1
Emission price 0.12 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.18 €
Lowest since issue 0.025 €
Delta-0.1x
Omega 8.831
Premium22.82x
Gearing91.91x
Moneyness 0.7826
Difference Strike -127.8 $
Difference Strike %-27.77%
Spread 0.04 €
Spread %50.63%
Theoretical value 0.0590
Implied Volatility 36.30 %
Total Loss Probability 86.31 %
Intrinsic value 0.000000
Present value 0.0590
Break even 453.60 €
Theta-0x
Vega0.01x
Rho-0x

Company Profile

McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.
Sector
-
More about the company

Ratings for McKesson Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: McKesson Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
587.8 USD
Average target price
599.9 USD
Spread / Average Target
+2.06%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant